Bookmark

Add to MyYahoo RSS

Medicines Company The News

News on Medicines Company The (Ticker: MDCO) continually updated from thousands of sources around the net.

5 hrs ago | Customer Interaction Solutions

The Medicines Company to Present New Data from its Infectious Disease ...

The Medicines Company today announced that a series of abstracts highlighting data from its Infectious Disease portfolio will be presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy , which takes place in Washington, DC from September 5-9, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Infectious Diseases, The Medicines Company, The Data Company, Law, Centers for Disease Control and Prevention, Minocin, Minocycline (generic)

9 hrs ago | Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Today PPLCONNECT announces centralizing all messaging app notifications in 1 place cross-device, including Facebook Messenger, What... )--UniPay Payment Management Platform expands Payment Card support for Private Brand Gift and Loyalty Cards as well as adding new Check 21 ACH Handling, Digital Currencies, ... )--Fitch Ratings assigns a rating of ... (more)

Comment?

Related Topix: Medicine, Healthcare Industry, Biotech, Infectious Diseases

Thu Aug 21, 2014

AmericanBankingNews.com

The Medicines Company Given "Neutral" Rating at Zacks

's stock had its "neutral" rating restated by Zacks in a report issued on Thursday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Aug 14, 2014

Seeking Alpha

Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?

Cellceutix's Brilacidina flagship one step antibiotic potentially simplifies patient results with a single dose possibly making Brilacidina the physicians first choice for fighting skin infections and oral mucositis.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, MRSA, Health, Healthcare Law, Law, Food and Drug Administration, Cubist Pharmaceuticals

Mon Aug 11, 2014

Chemistry World

Single shot antibiotic approved for skin infections

Intravenous antibiotic Orbactiv oritavancin , from US firm The Medicines Company , has been approved by the US Food and Drug Administration .

Comment?

Related Topix: Biotech, Healthcare Industry, Food and Drug Administration, MRSA, Health

Thu Aug 07, 2014

Barron's

The Medicines Co. Offers Investors 25% Upside

Late Wednesday, the Food and Drug Administration approved its new treatment for acute skin infections called Orbactiv, one of several experimental drugs Medicines Co.

Comment?

Related Topix: The Medicines Company, Biotech, Medicine, Healthcare Industry

JD Supra

Court Report -- Part II: August 2014

Medicines Company v. Accord Healthcare, Inc. et al. 1:14-cv-00626; filed July 24, 2014 in the Middle District of North Carolina Infringement of U.S. Patent Nos.

Comment?

Related Topix: 9, Biotech, Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Bristol-Myers Squibb, Pharmaceuticals

Freshnews

The Medicines Company and Alnylam Pharmaceuticals to Host RNAi...

The Medicines Company today announced that in collaboration with Alnylam Pharmaceuticals it will be hosting the "ALN-PCSsc for the treatment of Hypercholesterolemia" RNAi Roundtable webcast on August 14, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, The Medicines Company, Sirna Therapeutics, Alnylam Pharmaceuticals, Genetics

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

ROCKET FUEL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Rocket Fuel Inc. Following Disclosure of Lowered Outlook and Inventory Quality Concerns )--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has ... (more)

Comment?

Related Topix: Healthcare Law, Law, Cross Country Healthcare, Search Solutions Ltd, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Environmental Law

Wed Aug 06, 2014

BioSpace

FDA Approves The Medicines Company's Acute Skin Infection Drug Orbactiv

FDA Approves Orbactiv To Treat Skin Infections The U.S. Food and Drug Administration today approved Orbactiv , a new antibacterial drug to treat adults with skin infections.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, The Medicines Company, Infectious Diseases, Marketing

Mon Aug 04, 2014

Hispanic Business

Medicines Co /de - 10-Q - Management's Discussion and Analysis of...

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and accompanying notes included elsewhere in this quarterly report on Form 10-Q.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Minocin, Minocycline (generic), Boston Scientific, Medical Equipment

Pharmaceutical Online

Are You Properly Selecting Your CMO Partners?

I first met Angie Green at the 2013 WTG Global Pharma Manufacturing Summit in Boston.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Outsourcing

Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts-Part 3

Through knowing when the FDA is going to make a decision, momentum investors are able to make gains with the buildup ahead of the decision.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Science / Technology

Customer Interaction Solutions

The Medicines Company to Host Infectious Disease Care Investor and...

The Medicines Company has scheduled an Infectious Disease Care Investor and Analyst meeting for Wednesday, September 24, 2014 from 8:30 am to 12:00 noon.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Infectious Diseases, The Medicines Company, Parsippany, NJ

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The GEO Group Selected as Preferred Tenderer for Development and Operation of New 1,000-Bed Ravenhall Prison in Australia )--The GEO Group announced today that a GEO led consortium comprised of GEO's wholly-owned subsidiary, The GEO Group Australia Pty.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Jul 31, 2014

Freshnews

pSivida Corp. Reports ILUVIENA for Chronic Diabetic Macular Edema...

ILUVIEN has now been approved in nine EU countries , and is commercially available in the United Kingdom and Germany.

Comment?

Related Topix: pSivida, Biotech, Marketing, Medicine, Healthcare Industry, Food and Drug Administration, Glaucoma, Health

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••